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a b s t r a c t
In the present study, E6E7 and E6 proteins of human papillomaviruses (HPVs) associated with skin warts
and cancer were compared for their transforming and carcinogenic abilities in primary human
keratinocytes (PHKs). We show that E6E7 of cancer associated beta HPV types, notably 49 and 24, were
able to extend the life span and enhance the clonogenic efﬁciency of PHKs when maintained in serum
free/low calcium medium. Activities of the beta HPV E6E7 were lower than those of HPV16 E6E7.
In contrast, E6 proteins from HPV types detected in skin warts or cancer, notably 10, 49 and 38,
attenuated UVB induced protective responses in PHKs including cell death, proliferation arrest and
accumulation of the proapoptotic proteins, p53, bax or bak. Together, this investigation revealed
functional differences and commonalities between HPVs associated with skin warts and cancer, and
allowed the identiﬁcation of speciﬁc properties of beta HPVs supporting their involvement in skin
carcinogenesis.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Non-melanoma skin cancer (NMSC) and its early stage actinic
keratosis (AK), is the most frequent malignancy in the Caucasian
population. The major environmental risk factor for the develop-
ment of epithelial skin cancer is long term exposure to UV-radiation.
Recent studies provided evidence for a role for certain cutaneous
human papillomaviruses (HPV) in the multistep process of skin
carcinogenesis (reviewed in Akgül et al. (2006) and Nindl et al.
(2007)). Human papillomavirus (HPV) are small double stranded
DNA viruses found in a variety of proliferative lesions of epithelial
origin. High risk mucosal HPV types belonging to the alpha genus
(e.g. HPV16 and HPV18) are the etiological agents of anogenital
cancers as well as a subset of head and neck cancers whereas
low risk mucosal HPVs (e.g. HPV 6 and HPV11) cause low grade
squamous intraepithelial lesions or genital warts (Cogliano et al.,
2005; de Villiers et al., 2004; Bzhalava et al., 2013). HPVs that infect
the skin belonging to the genus alpha, gamma or mu, cause
generally no apparent infection or benign proliferative lesions,
warts. Some HPV types belonging to the beta genus have been
implicated in the carcinogenesis of NMSC (de Villiers et al., 2004;
Bzhalava et al., 2013). The earliest evidence for the involvement of
speciﬁc HPV types in human skin cancers originated from studies in
patients suffering from the very rare hereditary disease epidermo-
dysplasia verruciformis (EV) (Orth et al., 1979). Recent studies
suggest that EV types (beta HPV types) are also involved in NMSC.
HPV DNA of these types has been detected in NMSC and premalig-
nant skin lesions from organ transplant recipients as well as healthy
patients. Several HPV types and high copy number are detected in
premalignant AK lesions although viral load and prevalence is
decreased in skin cancer (Akgül et al., 2006; Nindl et al., 2007).
The mechanisms by which high risk HPVs may contribute to
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epithelial cell transformation and skin carcinogenesis is a subject of
current investigations (reviewed in Akgül et al. (2006), Nindl et al.
(2007), Klingelhutz and Roman (2012) and Tommasino (2014)).
The two main viral oncoproteins of the mucosal high risk alpha
HPVs are E6 and E7, which have been extensively studied.
The proteins display different functions towards the development
of cancer such as cellular immortalization and transformation,
alteration of epithelial differentiation, disruption of cell cycle con-
trol, inhibition of apoptosis and induction of genomic instability
(reviewed in Klingelhutz and Roman (2012), McLaughlin-Drubin
and Munger (2009), Howie et al. (2009) and Pim and Banks (2010)).
E6 and E7 exert their transforming activities, through their ability to
interact with a plethora of cellular tumor suppressor proteins,
induce their degradation and inactivate their function. E7 interacts
with pRb and other cell cycle regulators (McLaughlin-Drubin and
Munger, 2009). E6 targets proteins that control the survival, growth
and proliferation of human keratinocytes including the ubiquitin
ligase E6AP, p53, PDZ domain containing proteins, proapoptotic
proteins etc. (Howie et al., 2009; Vande Pol and klingenhutz, 2013).
Recent studies with the E6 and E7 proteins from beta HPV types,
such as 5, 8, 20 and 38, revealed biochemical and biological
activities that could lead towards epithelial cell carcinogenesis in
cooperation with UVB as well as independent of UVB (reviewed in
Nindl et al. (2007), Klingelhutz and Roman (2012) and Tommasino
(2014)). E6 proteins of beta HPV types are unable to promote p53
degradation but efﬁciently inhibit UV induced apoptosis by stimu-
lating the degradation of the proapoptotic protein bak (Jackson and
Storey, 2000; Jackson et al., 2000; Underbrink et al., 2008). The E6–
E7 genes of HPV 38 increase ΔNp73 expression which inhibits the
capacity of p53 to induce transcription of genes involved in growth
suppression and apoptosis (Accardi et al., 2006) and HPV 38 E7, but
not E7 of HPV 10 and 20, efﬁciently inactivates pRb and alters cell
cycle control (Caldeira et al., 2003). HPV 38 E6E7 activate NF-κB and
protect cells against TNF alpha and UV mediated apoptosis (Hussain
et al., 2011). In addition to the interaction with bak, recent studies
identiﬁed other interactors of the beta E6 proteins whose associa-
tion with E6 leads to disruption of their cellular functions including
the interaction of HPV 5 E6 with SMAD (Mendoza et al., 2006), HPV
8 E6 with TIP60 (Jha et al., 2010) and HPV 23 E6 with HIP2 (Muschik
et al., 2011). E6 of HPV 5, 8 and 38 interacts with p300 and impacts
p53 mediated apoptosis and keratinocyte differentiation (Muench
et al., 2010; Howie et al., 2011; Wallace et al., 2012). E6 proteins of
several cutaneous HPV types interact with mastermind-like coacti-
vators and repress Notch signaling (Tan et al., 2012). It is not clear
which interactions are speciﬁc to the cancer associated beta types.
In vitro cell transformation studies using rodent cells indicated the
abilities of E6 and E7 of several EV beta types to transform ﬁbroblastic
cell lines (reviewed in Nindl et al. (2007), Klingelhutz and Roman
(2012) and Vande Pol and Klingelhutz (2013)) and in cooperation
with activated ras, also primary rat kidney cells (Massimi et al., 2008).
Studies addressing the transforming abilities of cutaneous E6 and E7
proteins using primary human keratinocytes are limited. E6E7 of HPV
38 were demonstrated to immortalize primary foreskin keratinocytes
(Caldeira et al., 2003; Gabet et al., 2008) and this ability was also
recently demonstrated for E6E7 of HPV 49 (Cornet et al., 2012). The E6
protein of HPV 38 activates telomerase and prolongs the life span of
primary human keratinocytes with limited activity of E6 of HPV 5, 8,
20 and 22 (Bedard et al., 2008). Early studies showed a weak
immortalizing potential of HPV8 E7 in human keratinocytes
(Schmitt et al., 1994). In addition, the carcinogenic potential of
HPV8, 20 and 38 oncoproteins was demonstrated in transgenic mice
when expressed alone (Schaper et al., 2005; Dong et al., 2005) and in
combination with UV (Michel et al., 2006).
A critical step in the multistep process of skin carcinogenesis is
abrogation of terminal differentiation of squamous keratinocytes.
In a small number of studies carried out using monolayer and
organotypic cultures, E6 and E7 of different cutaneous HPV
types were demonstrated to induce alterations in keratinocytes
differentiation (Akgül et al., 2007; Boxman et al., 2001, Westphal
et al., 2009). One trait of the mucosal alpha HPVs that discrimi-
nates between high and low risk types is the ability of the E6E7
genes to inhibit terminal differentiation of primary human kera-
tinocytes (PHKs) triggered by serum and calcium (Schlegel et al.,
1988). Keratinocytes expressing HPV16 and 18 E6E7 overcome this
trigger and continue to proliferate leading to keratinocyte immor-
talization (Schlegel et al., 1988; Sherman and Schlegel, 1996).
Cutaneous HPV types were not evaluated before for this function.
To identify properties of cutaneous HPVs important for the
development of skin cancer, we performed a comprehensive
comparative functional analysis of several carcinogenic and trans-
forming functions of the HPV E6 and E7 proteins using primary
human keratinocytes. These include transforming functions that
have not been studied before in respect with the cutaneous HPV
types. In this study, HPV 10, a wart associated type that belongs to
the genus alpha-2 was compared to beta HPV types detected at
variable frequencies in SCC (Bzhalava et al., 2013) including HPV 8
(beta-1) the classical EV type, with the highest prevalence in skin
cancer, and HPV 24 (beta-1), 38 (beta-2) and 49 (beta-3) detected
at moderate prevalence (Bzhalava et al., 2013). Except from one
study (Cornet et al, 2012), HPV 49 has not been studied previously
for its transforming and carcinogenic abilities. The mucosal high
risk type HPV16, that belongs to the genus alpha-9 was included as
a positive control. The E6E7 proteins were tested for the ability to
enhance proliferation, extend survival and inhibit terminal differ-
entiation of PHKs induced by serum and calcium, while the E6
proteins were evaluated for the ability to alleviate proliferation
arrest and cell-death induced by UVB in PHKs, and to attenuate
UVB induced apoptotic signaling. The study highlighted important
differences in the biological properties of the analyzed HPV types.
Results
Ability of E6E7 from alpha and beta HPV types to inhibit terminal
differentiation of primary human keratinocytes induced by serum
and calcium
E6E7 of the “high risk” mucosal HPV types are capable to
immortalize foreskin keratinocytes that have been exposed
to serum/calcium differentiation trigger (Schlegel et al., 1988;
Sherman and Schlegel, 1996). Cutaneous HPV types were not
evaluated before for this function. Recombinant retroviruses carry-
ing the E6E7 genes of the cutaneous HPV types 8, 10, 24, 38, 49 and
the mucosal type, HPV 16, were used for stable transduction of the
E6E7 genes into PHKs. Expression of the transduced genes was
conﬁrmed by RT-PCR (described in “Materials and Methods”). PHKs
transduced with the E6E7 genes were exposed to differentiation
medium for 1 week, after which the cultures were split 1:3 in
medium containing 3 parts KSFM and 1 part DMEM containing 10%
serum. Cell split continued in the same manner each time they
reached 60–70% conﬂuence. Results are presented in Fig. 1A and S1.
Cultures transduced with the vector pLXSN as well as E6E7 of the
cutaneous HPV types did not survive more than 3 passages after the
differentiation trigger. At post-differentiation passage 2 (pdP2),
cultures with the cutaneous HPV E6E7 grew in merging colonies,
but did not ﬁll the ﬂask, whereas the 16E6E7 transduced PHKs grew
to full conﬂuence. In the next passage (pdP3), cultures of the
cutaneous HPV E6E7 contained mostly ﬁbroblasts and small islets
of differentiating keratinocytes, whereas cultures transduced with
16E6E7 showed small keratinocytes ﬁlling the ﬂask (Fig. S1 and data
not shown). Unlike keratinocytes transduced with the cutaneous
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HPV E6E7, proliferation of keratinocytes transduced with 16E6E7
continued in the subsequent passages until the experiment was
deliberately terminated (pdP12) (Fig. 1A). Experiments performed
with keratinocytes derived from adult skin explants produced
similar results (Fig. 1A).
The respective E6E7 proteins were also tested in another assay,
a quantitative colony assay that scores for resistance to serum/
calcium-triggered differentiation (Schlegel et al., 1988; Sherman
and Schlegel, 1996). PHKs were infected with two dilutions of viral
supernatants containing equal number of viral particles pre-
determined in a G418 colony resistance assay. After viral infection,
PHKs were maintained in serum-free growth media (K-SFM) to
reach 80–90% conﬂuence and subsequently switched to differen-
tiation medium containing high calcium and serum. Cells were
maintained in differentiation medium for 3 weeks to allow the
formation of colonies. Fig. 1B shows a representative colony assay
carried out with E6E7 of the different viral types and vector in
foreskin PHKs. Table 1 summarizes the collated results of all
experiments. As expected, HPV16 E6E7 produced colonies in all
experiments. The number of colonies was variable in the transduc-
tion of keratinocytes from different donors. Interestingly, E6E7 of
HPV 10 and to lower extent, 49 and 24, were also active in colony
formation although less than 16E6E7. This was reﬂected in the
lower number of experiments showing colonies and lower num-
ber of colonies formed (Fig. 1B and Table 1). E6E7 from HPV 8,
and 38 did not induce differentiation resistant colonies (Fig. 1B
and Table 1). Macroscopic appearance of the colonies induced by
10E6E7, 49E6E7 and 24E6E7 was similar to 16E6E7, however,
microscopically they were different (Fig. 1C). Colonies of 16E6E7
were composed of small, packed, proliferating keratinocytes
surrounded by terminally differentiated stratiﬁed keratinocytes.
The colonies of HPV 10, 49 and 24 E6E7 contained a narrow ring of
small proliferating keratinocytes at the border with the stratifying
keratinocytes whereas most of the colony center was comprised of
sparse, ﬂat and large keratinocytes (Fig. 1C and data not shown).
Fig. 1. Proliferative capacity of epidermal and foreskin human keratinocytes
transduced with E6E7 of diverse HPV types after exposure to serum/calcium
differentiation trigger. (A) serum/calcium immortalization assays. The mean num-
ber of post-differentiation passages carried out with the various E6E7 transduced
PHKs is shown. The collated results are from two independent experiments with
foreskin keratinocytes and three independent experiments with epidermal kerati-
nocytes. 8E6E7 was evaluated only in foreskin keratinocytes. Cultures of 16E6E7
were split until pdP12 or 16, after which the experiment was deliberately
terminated. The difference of 16E6E7 from the vector was statistically signiﬁcant
(Pr0.05). (B) Representative serum/calcium resistance colony assay. Macroscopic
appearance of colonies after 3 weeks maintenance in serum/calcium medium.
(C) Microscopic appearance of keratinocytes in the center of the colonies induced
by 16 and 49 E6E7. The collated results on number of positive experiments yielding
colonies and the mean number of colonies were presented in Table 1.
Table 1
Activity of E6E7 of diverse cutaneous HPV types in the induction of serum/calcium
resistant colonies in PHKs.
E6/E7 type Positive experiments Number of coloniesa
pLXSN 0/4 0
16E6/E7 4/4 33717
8E6/E7 0/2 0
10E6/E7 2/4 16713
24E6/E7 1/3 13
38E6/E7 0/3 0
49E6/E7 2/4 971.4
a Mean number of colonies produced from infection with 0.01 ml viral super-
natant containing 104 viral particles (G418 IU).
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Results from both these type of serum/calcium differentiation
inhibition assays indicated that although E6E7 of HPV types 10,
49 and 24 were able to delay terminal differentiation of PHKs
(colony formation), only HPV16 E6E7 were capable to overcome
growth arrest of PHKs induced by the differentiation trigger and
signiﬁcantly extend the proliferation of PHKs (immortalization
assays, Fig. 1A, Po0.05).
Ability of E6E7 from alpha and beta HPV types to enhance
proliferation and prolong the life span of primary human
keratinocytes maintained in low-calcium and serum-free medium
The E6 and E7 genes of HPV16 and HPV18 were shown to be
able to immortalize PHKs maintained in low-calcium and serum
free medium ((Hawley-Nelson et al., 1989; Hudson et al., 1990).
Similar activity was reported for E6E7 of HPV 38 (Caldeira et al.,
2003; Gabet et al., 2008) and 49 (Cornet et al., 2012) when primary
human keratinocytes were cultured on a ﬁbroblast feeder layer.
The selected HPV E6E7 were tested in immortalization assays
using neonatal foreskin PHKs grown in serum free medium with-
out feeder layer. Keratinocytes were transduced with the various
E6E7 genes, selected in G418 medium and further sub-cultured
in KSFM. Post-selection passages (psP) were carried out when
keratinocytes covered at least 60% of the ﬂask. Results are shown
in Fig. 2 and Table 2. Consistent with our previous report using the
same protocol (Asadurian et al., 2007), 16E6E7 transduced PHKs
showed extended proliferation ability reaching more than 10 post-
selection passages at which point the experiment was deliberately
terminated. PHKs transduced with E6E7 of the cutaneous HPV
types showed different proliferation abilities. E6E7 of HPV 8 and
38 only slightly extended the proliferation of keratinocytes over
that of vector (Table 2). PHKs transduced with E6E7 of HPV 24 and
particularly 49, showed signiﬁcant proliferation capacity with
extended growth over 6 passages in 40–50% of the experiments,
respectively, and in few experiments, also over 10 passages
(Table 2). Keratinocytes transduced with 10E6E7 showed life span
similar to that of vector keratinocytes. Keratinocyte cultures
transduced with the different E6E7 genes had different morphol-
ogy in the early passages (Fig. 2A). PHK cultures of 16E6E7
consisted of small, packed, proliferating keratinocytes at all pas-
sages (Fig. 2). Early 38E6E7 passages showed heterogeneous
cultures, comprising of small proliferating keratinocytes and large
ﬂat cells with low nucleus/cytoplasm ratio. Cultures of HPV 8 and
24 had a similar phenotype. Cells in the 49E6E7 cultures had a
distinct appearance. They grew in clusters in which the borders
between cells were not visible and had a slightly irregular shape.
Small and large keratinocytes were present in the same
culture (Fig. 2A). Cultures transduced with 10E6E7 were composed
mostly of ﬁbroblasts and very few large, apparently differentiated,
keratinocytes (Fig. 2A).
PHKs that ceased proliferation (before reaching passage 10)
were maintained for 6–8 weeks in KSFM and examined for the
appearance of re-emerging colonies which reﬂect the ability of
quiescent keratinocytes to overcome cell cycle arrest or growth
crisis and resume proliferation. PHKs transduced with vector or
E6E7 of HPV 10 and 38 did not produce re-emerging colonies.
Islets of keratinocytes appeared in a signiﬁcant proportion of the
Fig. 2. Morphology and growth efﬁciency of PHKs transduced with E6E7 of diverse HPV types at different passages after G418 selection. After retroviral transduction and
G418 selection, PHKs were maintained in KSFM and when reaching 60–70% conﬂuence they were split. Culture split was terminated when ﬁbroblast overgrowth was noted
at which point the remaining cells were kept in KSFM for 6–8 weeks. (A) Microscopic appearance of representative keratinocyte cultures transduced with E6E7 of the
indicated HPV types at different post-selection passages (psPs), magniﬁed X40. (B) Time length (days) between post-selection passage 2 and 3. Results are from 3–5
independent experiments with each E6E7, except 8E6E7 which was tested in one experiment. The asterisk denotes signiﬁcant difference from vector (Pr0.05).
(C) Macroscopic and Microscopic appearance of re-emerging colonies induced by E6E7 of HPV49. The cultures were stained 4 weeks after overgrowth of ﬁbroblasts occurred.
The collated results on the mean number of passages reached by the various E6E7 PHKs and efﬁciency of re-emerging colony formation were presented in Table 2.
Table 2
Number of post-selection passages in serum-free medium and number of experi-
ments producing re-emerging colonies in PHKs transduced with diverse cutaneous
HPV E6E7.
HPV type Post-selection passages Re-emerging colonies
Z4 Z6 Z10
HPV16 E6/E7 6/6 6/6 6/6 NDa
pLXSN 1/6 0/6 0/6 0/6
HPV8 E6/E7 3/5 2/5 0/5 2/5
HPV10 E6/E7 1/5 0/5 0/5 0/5
HPV24 E6/E7 3/5 2/5 1/5 2/4
HPV38 E6/E7 2/5 1/5 0/5 0/5
HPV49 E6/E7 4/6 3/6 2/6 4/4
a ND—not done.
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24 and 49 E6E7 long term cultures (Fig. 2C and Table 2). Induction
of re-emerging colonies was also observed in PHKs transduced
with HPV 8 (Table 2).
An additional evaluation of the growth potential conferred by
the various E6E7 genes was to look at the number of days it took
for each culture to reach 60–70% conﬂuence (at which point the
culture was split). As most of the cultures did not survive more
than 4 passages after selection, we examined the time length
between psP2 and psP3 (Fig. 2B). The average time for the vector
culture was 13 days. HPV16 exhibited signiﬁcantly shorter length
(5.272.2). PHKs transduced with HPV24, 38 and 49 E6E7 had
a shorter time length than the vector (about 9 days) however the
difference from vector was statistically signiﬁcant only for 49E6E7.
E6E7 of HPV 8 and 10 did not shorten the time length as compared
to vector (Fig. 2B).
E6E7 of the selected cutaneous HPV types were also tested for
enhanced proliferation capacity in a clonogenicity assay which
evaluates the ability of a single cell to proliferate and form a
colony. Keratinocytes at psP2 after selection were seeded sparsely
in 3 dilutions into 6 wells plates and allowed to grow for 2 weeks
in KSFM after which the number of colonies containing at least 50
cells was determined (Fig. 3A). PHKs transduced with HPV16, 24,
38 and 49 E6E7 showed signiﬁcantly higher clonogenic efﬁciency
as compared to vector transduced PHKs (Fig. 3B). E6E7 of HPV 8,
the classical EV type with the highest prevalence in skin cancer
(Bzhalava et al., 2013), also enhanced the clonogenic efﬁciency of
PHKs, though signiﬁcantly less than E6E7 of HPV 24, 38 and 49.
Cultures transduced with E6E7 of HPV10 exhibited clonogenic
efﬁciency comparable to vector (Fig. 3A and B).
Attenuation of UVB induced cell death and proliferation arrest
in PHKs by E6 proteins of alpha and beta HPV types
UVB irradiation induces proliferation arrest and apoptosis in
human keratinocytes (Lippens et al., 2009). Previous reports
indicated that E6 proteins of diverse cutaneous HPV types inhibit
apoptosis induced by UVB irradiation and this was associated with
reduction of the levels of the proapoptotic protein, bak (Jackson
and Storey 2000; Jackson et al., 2000; Underbrink et al., 2008).We
examined the effect of UVB irradiation on PHKs stably transduced
with the E6 proteins of the ﬁve selected cutaneous HPV types
described above. These include HPV49, the cancer associated beta
type which has not been studied before in respect with its UVB
counteracting activity, and HPV 10 whose effect has not been
evaluated in human keratinocytes. The E6 proteins were tested for
their ability to prolong viability and proliferation of PHKs after
exposure to UVB.
Cell viability after UVB irradiation was determined using an
XTT reagent assay (Fig. 4A). Viability was determined 24 and 48 h
after irradiation. PHKs transduced with HPV 10, 24, 38 and 49 E6,
showed consistently higher percent of viable cells as compared to
vector, with the difference being statistically signiﬁcant at 24 h
(Fig. 4A). Viability of cells transduced with HPV 8 E6 dropped
rapidly, faster than vector cells, reaching 6.7% and 2.3% at 24 and
48 h, respectively (Fig. 4A).
To test the proliferative status of the UVB irradiated keratino-
cytes, we examined the expression of Ki67, a well-known marker
for cell proliferation (Scholzen and Gerdes, 2000). Ki67 is expressed
during all phases of the cell-cycle only in proliferating cells and is
Fig. 3. Clonogenic efﬁciency of foreskin PHKs transduced with E6E7 of diverse HPV types. Clonogenicity assays were carried out after retroviral transduction and PHK
selection in G418 medium. (A) Representative clonogenicity assay with the indicated E6E7 PHKs. (B) The mean colony number produced by the different E6E7 transduced
PHKs per 1000 seeded cells7SD. Three independent transduction experiments were carried out. Results shown are averages from 2 experiments where vector colony
numbers were in the same range. The asterisk denotes signiﬁcant difference from vector, Pr0.05.
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Fig. 4. Cell Viability and Ki67 expression in PHKs transduced with E6 of diverse HPV types before and after UVB exposure. (A) PHKs transduced with the various E6 genes or
vector were exposed to UVB irradiation and then suspended and plated into 96 well plates. Cell viability was determined at 24–48 h after plating using the XTT reagent kit.
Results are from 3 independent transduction experiments. Signiﬁcant difference from the vector cells (Pr0.05) was marked with asterisk. (B, C) PHKs transduced with E6 or
vector were exposed to UVB and then further incubated for 5 or 24 h. Slides of non-irradiated controls (0 h) and irradiated PHKs (5 and 24 h) were ﬁxed and stained for Ki67.
The proportion of PHKs showing brightly stained ﬂuorescent nuclei in each culture was determined using immunoﬂuorescence confocal microscopy. (B) Nuclear staining of
Ki67 in representative E6 cultures and vector. (C) The mean proportion of Ki67 stained cells at 5 and 24 h relative to 0 h7SD in the different E6 transduced PHKs. Results are
from 3 independent transduction/UVB experiments. Signiﬁcant difference from vector cells (Pr0.05) was marked with asterisk.
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absent in resting cells. During G1 Ki67 antigen is detected in a large
number of discrete foci in the nucleoplasm. During S and G2 Ki67
was found either restricted to the nucleoli, throughout the nucleus
or in brightly stained nuclear foci in addition to diffuse nucleoplas-
mic distribution (Scholzen and Gerdes, 2000). Before the exposure
to UVB, PHKs transduced with the vector or E6 proteins contained a
large proportion of cells with brightly stained nuclear foci (Fig. 4B
and Fig. S2). At 5, and particularly at 24, hours after irradiation, the
proportion of cells with stained nuclei decreased and staining
became more diffusely distributed in the nucleus or absent.
The decrease in the proportion of stained nuclei was slower in
keratinocytes transduced with E6 of HPV10, 38 and 49, whereas in
keratinocytes expressing 8E6 the decrease was more rapid (Fig. 4B
and C and Fig. S2). Cultures expressing 16E6 showed higher percent
of basal Ki67 stained cells and the drops after UVB were slower
(Fig. 4C and Fig. S2). These results suggest that different beta HPV
E6 proteins may enhance or delay the proliferation arrest induced
by UVB.
Attenuation of UVB induced apoptosis signaling in PHKs by E6
proteins of alpha and beta HPV types
UVB irradiation induces apoptosis in the skin, indicated by
activation of procaspase-3, and increased levels of the proapopto-
tic proteins p53, bak and bax (Lippens et al., 2009). An important
player in the UVB induced response is p53. The levels of p53 in the
skin rise upon UVB irradiation due to its stabilization and this
leads to cell cycle arrest and DNA repair or if DNA damage is
excessive to activation of apoptosis (Lippens et al., 2009). The
phosphorylation of p53 at serine 15 mediated by ATM or ATR
kinases acts as a nucleation event that promotes subsequent
sequential modiﬁcations of p53 (Meek and Anderson, 2009). As
UVB induced phosphorylation of p53 that leads to its accumula-
tion and transcriptional activation is rapid, we looked at p53
phosphorylation at serine 15 and p53 protein levels at short time
intervals after irradiation (30 min–2 h) (Fig. 5). A dramatic increase
in the levels of phosphorylated p53 was observed in vector cells at
30 min after irradiation that remained high up to 2 h and then
decreased. This was accompanied with a moderate increase in p53
protein levels evident at 30 min–2 h after UVB exposure, followed
with a decrease at 5 h. A similar temporal elevation in the levels of
serine 15 phosphorylated p53 was observed in cells transduced
with E6 of HPV 8, 10, 24, 38 and 49. However, despite p53
phosphorylation in the E6 transduced keratinocytes, no increase
in p53 protein levels was observed in any of the HPV E6
transduced keratinocytes, where the decline in p53 levels started
shortly after irradiation (30 m). The drops were prominent in cells
transduced with E6 of HPV10 and 49, but also evident in
keratinocytes transduced with E6 of HPV 8, 24, and 38 (Fig. 5).
In experiments where p53 levels were examined at 5 and 24 h
post-irradiation an enhanced decline in p53 was observed in PHKs
transduced with E6 of HPV 49, 8 and particularly 10, reaching
almost undetectable levels at 24 h (Fig. S3). In most experiments
carried out with keratinocytes from different donors, no signiﬁ-
cant differences in the constitutive, basal, levels of p53 were noted
between vector and the cutaneous HPV E6 transduced PHKs.
As expected, in all the experiments, PHKs transduced with 16E6
exhibited very low basal levels of p53 due to the degradation
induced by E6 (Scheffner et al., 1990) and the levels of p53 did not
increase upon UVB irradiation (Fig. 5 and Fig. S3).
These results suggest that E6 proteins from alpha and beta HPV
types associated with skin warts or cancer may interfere with p53
signaling by preventing the stabilization of p53 following UVB
irradiation.
Bax and bak are pro-apoptotic members of the Bcl-2 family that
function in mitochondrial membrane permeabilization and the
release of cytochrome c, major events in apoptosis induction
(Scorrano et al., 2003; Ghiotto et al, 2010). The levels of bak and
bax increase in the skin after exposure to UVB (Lippens et al.,
2009). E6 proteins of some beta and alpha cutaneous HPV types
Fig. 5. Changes in p53 levels and phosphorylation after UVB exposure in PHKs transduced with E6 of diverse HPV types. P53 levels and phosphorylation at serine 15 were
examined at 30 min–2 h after exposure to UVB using the same immunoblot. Blots from representative experiments are shown. The effect of E6 on p53 protein levels was
determined in at least 3 independent transduction/UVB experiments with the vector and 16E6 included in all experiments. The bar graphs show average7SD of the p53
levels after UVB exposure relative to 0 h. The asterisk denotes signiﬁcant difference from vector at the same time point (Pr0.05). Phosphorylation of p53 was examined in
2 different experiments. Average7SD of the phosphorylated p53 levels relative to 0 h are shown.
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were previously shown to reduce the expression levels of bak or
prevent its accumulation after UVB irradiation concomitant with
inhibition of apoptosis (Jackson et al., 2000; Underbrink et al.,
2008). E6 proteins of HPV 10, 24 and 49 were not tested in human
keratinocytes. In the experiments carried out herein, similar basal
levels of bak expression were detected in PHKs transduced with
the different E6 proteins which were comparable to the vector
transduced PHKs (Fig. 6A). Keratinocytes transduced with the
vector repeatedly showed a moderate increase in bak levels at
5 and 24 h after UVB exposure. All tested E6 proteins were active
in attenuation of bak accumulation. Keratinocytes transduced with
8E6, 24E6 and 38E6 showed no change in bak levels whereas in
Fig. 6. Changes in levels of expression of bak, bax and survivin after exposure to UVB. Levels of expression of bak (A), bax (B) and survivin (C) in the E6/vector transduced
PHKs were determined at 5 and 24 h after UVB exposure. Blots from representative experiments are shown (A–C). The effects of the E6 protein on the proapoptotic (bax, bak)
and survival (survivin) proteins was analyzed in at least 3 independent transduction/UVB experiments with vector and 16E6 included in each experiment. The bar graphs
show average7SD of the protein levels after UVB exposure relative to 0 h. The asterisk denotes signiﬁcant difference from vector at the same time point (Pr0.05).
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PHKs transduced with 16E6, 10E6 and to a less extent 49 E6, a
decrease in bak levels was noted which was most pronounced at
24 h after irradiation (Fig. 6A).
Similarly to bak, bax basal levels detected in vector and E6
transduced PHKs were comparable (Fig. 6B). Upon UVB irradiation,
levels of bax increased in the vector transduced keratinocytes.
In PHKs transduced with 16E6, a progressive decrease in bax levels
was detected. Decreases in bax levels after UVB exposure were
also noted in PHKs transduced with E6 of HPV 8, 10, 38 and
49 (Fig. 6B ). Bax levels did not change signiﬁcantly in PHKs
transduced with E6 of HPV 24. The overall results from bax and
bak analyses indicated that E6 proteins of cutaneous HPVs are
capable of preventing their accumulation induced by UVB and E6
proteins of some types can even reduce their levels after UVB
exposure, notable 10 and 49 E6 (Fig. 6A and B).
Survivin, a member of the inhibitor of apoptosis protein (IAP)
family has an important role in inhibition of programmed cell
death, downstream of caspase-3 (Yang and Li, 2000. Western blot
analyses indicated that survivin constitutive expression levels
were different in PHKs transduced with the various E6 types
(Fig. 6C). Survivin levels were almost undetectable in the vector
transduced cultures but considerably higher in PHKs transduced
with E6 of HPV 16, 38, 24 and 49. The levels of survivin were low
in PHKS transduced with E6 of HPV 8 and 10 and comparable to
vector. UVB irradiation caused decrease in the expression levels of
survivin in all transduced cultures. The drops in survivin in PHKs
transduced with 38 and 49 E6 were slower than in PHKs
transduced with 24E6, where the decline was evident already at
5 h after irradiation (Fig. 6C). These results suggested that some
cutaneous HPV types may blunt apoptosis downstream of caspase-
3 activation, due to elevated expression of survival proteins such
as survivin (Fig. 6C).
In all the experiments carried out with the HA tagged E6
proteins (HPV16, 38, 49, and 8), a reduction in the levels of E6
expression was observed after UVB irradiation that was most
pronounced at 24 h after irradiation (Fig. S4). E6 basal levels of
expressionwere however at comparable levels in all the HA tagged
E6 transduced cultures.
Discussion
Studies in recent years with E6 and E7 proteins of selected
cutaneous HPV types, mostly EV types from the beta genus,
revealed biochemical and biological activities that could lead
towards cell transformation and carcinogenesis either when acting
alone or in cooperation with UVB radiation (reviewed in Nindl
et al. (2007), Klingelhutz and Roman (2012) and Tommasino
(2014)). It has not been established which of these activities are
characteristic to the cancer associated beta types and potentially
contribute to the carcinogenic process, and which are shared with
the wart associated HPV types, and presumably needed for the
viral life cycle. This study aimed to identify properties that
distinguish between the two HPV categories (Tables S1 and S2).
Transforming abilities of E6E7 of different cutaneous HPV types
in primary human keratinocytes
High risk mucosal HPV types inhibit terminal differentiation of
human keratinocytes triggered by serum and calcium and induce
their immortalization (Schlegel et al., 1988; Sherman and Schlegel,
1996). In the study herein, we show that unlike 16E6E7, none
of the cutaneous HPV E6E7 proteins were capable to extend the
proliferation of PHKs after the serum/calcium trigger. Interestingly,
in another assay that evaluates the ability of E6E7 to confer
resistance to serum/calcium differentiation, a quantitative colony
assay (Schlegel et al., 1988), HPV 10, 24 and 49, exhibited a modest
activity. HPV10 showed the highest colony formation activity
among the active HPV types. HPV 10 is part of the alpha-PV genus
(de Villiers et al., 2004). In skin, it is usually associated with benign
warts (de Villiers et al., 2004) and considered to be a benign type,
though it has been found in carcinomas of some organ transplant
patients (OTRs) (Storey et al., 1998) and non-typical cases of EV
(Zahir et al., 2013). In the mucosal HPV types, only high-risk types
harbor the ability to induce serum/calcium resistant colonies in
human keratinocytes (Schlegel et al., 1988). However, as evident
by the morphology of the cells in the colonies, E6E7 of HPV 10, 24
and 49 may have inhibited the stratiﬁcation and death of kerati-
nocytes, which occur during terminal differentiation (Candi et al.,
2005), but not the entire differentiation process. The results
obtained from the serum/calcium immortalization assays further
support this conclusion. Thus, cells in the colonies induced by
HPV10, 24, and 49 E6E7 lack extended proliferative capacity, but
rather represent live cells whose stratiﬁcation and death have
been inhibited, similar to the effect demonstrated previously for
16E6 (Sherman and Schlegel, 1996). The fact that HPV10 was
capable to induce serum/calcium resistant colonies implies that
this function may facilitate viral replication by allowing viral
reproduction to proceed in cells whose viability was extended.
The transforming functions of the cutaneous HPV types were
uncovered however in assays that evaluated the ability of E6E7 to
prolong the life span and enhance proliferation of human kerati-
nocytes maintained in low calcium- and serum free-medium
(Table S1). Only the cancer associated beta HPV types showed
activity in these assays with variable potency and no species
speciﬁcity. HPV 24 and HPV49 that belong to the beta-1 and
beta-3 species, respectively (de Villiers et al., 2004), and are
represented at moderate incidence in SCC (Bzhalava et al., 2013)
showed the highest activities. PHKs transduced with E6E7 of HPV
49 and 24 were the only ones reaching late passages (over 10 post-
selection passages), produced re-merging colonies in high propor-
tion of experiments, exhibited shorter time length between
passage 2 and 3 after G418 selection, and exhibited signiﬁcantly
higher clonogenic efﬁciency. HPV 49 and 24 E6E7 were less
effective however than 16E6E7 in all these assays, thus supporting
the notion that cutaneous beta HPV types are less oncogenic than
the mucosal high risk alpha HPV types. Our results showing the
extended and enhanced growth capacity of keratinocytes trans-
duced with E6E7 of HPV 49 and 24 are consistent with, and further
substantiate, one recent report that showed the ability of E6E7 of
these viral types to prolong the life span of human keratinocytes
(Cornet et al., 2012). Interestingly, PHKs transduced with 38E6E7
(beta-2) exhibited high clonogenic efﬁciency, comparable to that
of 49E6E7, but displayed only slightly prolonged life span, unlike
previous reports which indicated the immortalizing ability of
38E6E7 (Caldeira et al., 2003; Gabet et al., 2008; Muench et al.,
2010; Cornet et al., 2012). However, all these studies described a
long period of 2–3 months with no apparent growth after which
the cells started proliferating and furthermore, unlike our immor-
talization protocol, keratinocytes were maintained on ﬁbroblast
feeder layers during these prolonged periods. The lower immor-
talizing activity of HPV38 E6E7 could be due to the lower levels of
hTERT induced by 38E6 in human keratinocytes (Cornet et al.,
2012). HPV 8 which also belongs to the beta-1 species and is
detected at high prevalence in SCC (Bzhalava et al., 2013),
exhibited only moderate ability to prolong the life span of human
keratinocytes and enhance their clonogenic efﬁciency. This could
be related to the lower ability of the E6 protein of HPV 8 to induce
hTERT in human keratinocytes (Bedard et al., 2008). E6E7 of HPV
8 and 38 may however express other functions that lead to
abrogation of keratinocyte growth and differentiation which have
not been tested in the study herein including the ability of 8E6 to
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interact and degrade p300 (Howie et al., 2011), ability of 8E7 to
alter the proliferation and differentiation of adult epidermal
keratinocytes when grown in organotypic cultures (Akgül et al.,
2007; Westphal et al., 2009) and ability of both E6 and E7 to
increase the number of keratinocytes with stem cell properties
(Hufbauer et al., 2013). Most importantly, this study showed that
HPV10 E6E7 did not prolong the life span, induce re-emerging
colonies, or enhance the clonogenic capacity of PHKs, consistent
with the notion that the later activities reﬂect real transforming
abilities which 10 E6E7 lack and thus support the designation of
HPV 10 as a low risk type.
Abrogation of the protective response of human keratinocytes
induced by UVB irradiation
Keratinocytes are equipped with efﬁcient protective measures
to handle UVB induced DNA damage. These include cell-cycle
arrest, DNA repair, inﬂammation and if DNA damage is excessive,
apoptosis, resulting in the formation of so-called sun-burn (Lip-
pens, 2009). Experimental evidence indicated that infection with
beta HPV types may facilitate the persistence of DNA-damaged
cells within the skin through interfering with the UVB induced
DNA damage responses and inhibiting apoptosis (Akgül et al.,
2006). The results herein show that both skin wart and cancer
associated, alpha and beta, HPV types are capable to counteract
protective responses induced by UVB in human keratinocytes
(Table S2)
Cell viability (XTT assays) and proliferation (Ki67) measure-
ments in PHKs indicated signiﬁcant decreases at 24–48 h after
UVB exposure. The decline in the proportion of cells expressing
Ki67, cell proliferation marker, was detected already after 5 h. The
E6 proteins of most tested cutaneous HPV types attenuated the
UVB induced responses, although to a different extent. The E6
protein of HPV 49 and 38 signiﬁcantly attenuated cell death and
proliferation arrest whereas HPV24 E6 sustained keratinocyte
viability, but only slightly prolonged the proliferation of keratino-
cytes. Interestingly, an enhanced decline in cell viability and
proliferation was detected in HPV 8 transduced PHKs. This was
accompanied with an enhanced activation of apoptosis indicated
by accelerated cleavage of procaspase-3 (data not shown). Inability
to detect the antiapoptotic effect of 8E6, unlike previous studies
(Underbrink et al., 2008; Struijk et al., 2008), could be due to lack
of capacity to inhibit apoptosis down stream of caspase activation
or lack of ability to counteract cell death induced by other
mechanisms than apoptosis. Supporting the latter possibility is
data from a recent study by one of the above cited groups (Wallace
et al., 2012), indicating that PHKs transduced with 5, 8, and 16
were more sensitive to UVB irradiation when cell viability was
evaluated. Most important, the study herein showed that HPV10
E6 signiﬁcantly reduced the UVB induced cell death and prolonged
proliferation of keratinocytes to a level similar to 49E6.
Comparative analysis of the effects of the various E6 proteins
on expression of proteins that mediate proliferation arrest and
mitochondrial apoptosis, p53, bax, and bak, identiﬁed a general
common ability of all tested E6 proteins to attenuate their
elevation after UVB exposure (Table S2). We identiﬁed the ability
of all tested cutaneous HPV E6 proteins to prevent the accumula-
tion of p53 and even reduce its levels after UVB exposure with
HPV 10 and 49 being more efﬁcient than HPV 8, 24 and 38. The
high efﬁciency of 10E6 in targeting p53, could be due to its ability
to associate with E6AP (Thomas et al., 2013). Only 16E6 decreased
the basal expression of p53, including 49E6 that was previously
reported to degrade p53 in human keratinocytes (Cornet et al.,
2012). Although p53 accumulation was inhibited by all E6 proteins,
elevation of p53 phosphorylation at serine 15 which is important
for p53 stabilization (Meek and Anderson, 2009) was still detected,
suggesting the ability of the cutaneous HPV E6 proteins to
uncouple p53 destabilization from p53 phosphorylation at serine
15. In a previous study, E6 proteins of HPV 5, 8 and 38 were shown
to attenuate phosphorylation of p53 at serine 15 and 37, and delay
the accumulation of p53 (Wallace et al., 2012). The peak times for
p53 phosphorylation and protein accumulation after UVB expo-
sure were different however from the study herein (4–8 h com-
pared to 30 min–2 h) which could be due to the different UVB
doses used in the two studies (10 mJ/cm2 versus 30 mJ/cm2). The
E6 proteins may have induced destabilization of p53 by inhibiting
p53 phosphorylation at other serine or threonine residues or by
preventing the acetylation of p53 via p300 that contributes to p53
stability by blocking ubiquitylation (Meek and Anderson, 2009).
Previous reports demonstrated the ability of HPV 5, 8 and 38 E6 to
target p300 for degradation (Muench et al., 2010; Howie et al.,
2011; Wallace et al., 2012) and attenuate p53 acetylation (Wallace
et al., 2012).
Similarly to p53, bax and bak accumulation after UVB exposure
was attenuated by the E6 proteins. The study herein identiﬁed the
ability of E6 of HPV 49 to prevent the accumulation of both bax
and bak, and even reduced their levels after UVB exposure.
Importantly, the study herein showed that 10E6, the wart
associated type, signiﬁcantly reduced bak and bax levels in PHKs
after UVB exposure, consistent with previous observations show-
ing bak degradation and inhibition of apoptosis in HT1080 cells
(Jackson and Storey, 2000). The data herein further substantiate
and support the notion that preventing apoptotic signaling of bax
or bak in human keratinocytes is a common trait of many skin HPV
types of the genus alpha and beta, including HPV types detected in
skin warts.
Although all tested E6 proteins exhibited certain level of
activity in preventing the accumulation of the proapoptotic
proteins p53, bax or bak after UVB exposure, cleavage of cas-
pase-3, with accumulation of the active apoptotic product p17, was
detected in all the E6 expressing PHKs (data not shown). However,
despite caspase-3 cleavage the XTT assays indicated that PHKs
transduced with E6 of HPV 49, 38, 10 and 24 survived longer after
UVB exposure. This could result from protection of keratinocytes
from a caspase-independent cell death or attenuation of cell death
downstream of caspase-3 by inhibitors of apoptosis (IAPs) (Altieri,
2010). Indeed, this study identiﬁed the expression of survivin in
PHKs transduced with E6 of 49, 38 and 24 as well as 16, but not in
cells transduced with 10E6. Survivin, a member of the family of
inhibitors of apoptosis (IAP) proteins, has an important role in
inhibition of programmed cell death (Altieri, 2010). Survivin was
previously shown to be transactivated by HPV16 E6 and to have an
important role in the 16E6 anti-apoptotic function (Borbély et al.,
2006). Expression of cIAP1, cIAP2 and XIAP proteins was shown to
be induced in PHKs transduced with E6/E7 of HPV38 through
activation of the canonical NF-κB pathway (Hussain et al., 2011).
Whether E6 proteins of other cutaneous HPV types, such as
49, 24, and particularly 10, have a similar ability needs further
investigation.
In summary, by comparing the activities of the E6 and E7
proteins of HPV types associated with skin warts and cancer in a
relevant cell system of primary human keratinocytes, this study
identiﬁed viral transforming activities that are distinctive for the
cancer associated beta HPV types and thus potentially important
for the carcinogenic process. On the other hand, we found that the
ability to attenuate UVB induced protective responses is common
to E6 proteins of both groups. HPVs in general may have acquired
this capacity as they need to counteract the DNA damage response
to replicating HPV genomes. For cutaneous HPVs, this ability may
be needed to speciﬁcally abrogate UVB induced protective
responses and thus facilitate viral replication in the skin which is
constantly exposed to UVB radiation. Other activities in response
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to UVB, such as the ability to allow persistence of the DNA damage
induced by UVB by preventing DNA damage repair, may be more
important for HPV carcinogenicity (Giampieri and Storey, 2004;
Wallace et al., 2012). Nonetheless, the present investigation
identiﬁed HPV 49 as a potent beta HPV type that is capable of
promoting growth and proliferation of human keratinocytes, and
resisting UVB induced protective responses, thus potentially
enabling persistent viral replication in the skin.
Materials and methods
Human papillomavirus E6 and E6E7 plasmids and production
of recombinant retroviruses
LXSN vectors carrying the E6 and E7 (E6E7) or E6 genes were
used for preparation of recombinant retroviruses. These include
E6E7 of HPV 24, 38, 49 (Cornet et al., 2012), the common skin type,
HPV10 (Massimi et al., 2008) and HPV 8 which was kindly
provided by B. Akgul (Institute of Virology, University of Cologne).
HPV8 E6HA and HPV38 E6HA, cloned in the pLXSN-3HA gateway
vector (Bedard et al., 2008), were kindly provided by D. Galloway
(Fred Hutchinson Cancer Research Center, Seattle, Washington).
The E6s of HPV 24 and 10 cloned into pLXSN were described
previously (Massimi et al., 2008). These plasmids express the
native E6 proteins. HPV49 E6HA was constructed by PCR with
primers containing the HA tag at the C-terminus of E6, as
previously described (Sherman and Schlegel, 1996), and cloned
into the pLXSN vector. High titer retroviral supernatants were
generated by transient transfection of the Phoenix cells (ampho-
tropic virus) as described previously (Zehbe et al., 2009).
Retrovirus supernatants were titrated for infectious virus based
on the induction of G-418 resistant colonies in NIH/3T3 cells. Viral
supernatants containing 104–5104 G418 colony forming
particles (CFP) were used for infection of primary human
keratinocytes.
Cell cultures and infection with recombinant viruses
NIH 3T3 and phoenix cells were cultured in Dulbecco's mod-
iﬁed Eagle's medium (DMEM) with 10% fetal calf serum. Primary
human keratinocytes (PHKs) were prepared from neonatal fore-
skins as described previously (Asadurian et al., 2007) or obtained
from skin explants (The Laboratory of Experimental Surgery,
Hadassah University Hospital). Foreskins were obtained under
the approval of the Helsinki Committee, The Wolfson Medical
Center, Holon, Israel, application: 9-2009-0052/1069. All samples
were anonymized. Keratinocytes were grown in serum free
medium, keratinocyte-SFM (KSFM), supplemented with 5 ng/ml
epidermal growth factor (EGF) and 50 μg/ml bovine pituitary
extract (BPE) (Gibco by life technologies) (Sherman and Schlegel,
1996; Asadurian et al.,2007).
Infection of human keratinocytes with retroviral supernatants
was carried out as described previously (Asadurian et al., 2007).
For stable transduction of the papillomavirus genes, keratinocytes
were selected in medium containing G418 200 mg/ml for 3 days.
Stable expression of the E6E7 and E6 transduced genes in PHKs, in
the various experiments (described below), was veriﬁed by RT-PCR
as described previously (Milrot et al., 2012). The primers for
detection of the E6 and E6E7 mRNAs are presented in Table S3.
Representative RT-PCRs from different experiments are shown in
Fig. S5. Expression of the HA tagged 8E6, 38E6, 49E6 and 16E6
was veriﬁed also by Western blot with the anti HA antibody.
Representative blot is shown in Fig. S4.
Induction of colonies resistant to serum/calcium-triggered
differentiation in PHKs
Colony assays were carried out as described previously
(Sherman and Schlegel, 1996) except that viral supernatant stock
dilutions were used to transduce the E6E7 genes (101–102 of
viral supernatants containing 104 G418 CFP/ml). PHKs were seeded
in 25 cm ﬂasks and infected in duplicates with 1 ml of the virus
dilution in KSFM containing 10 mg/ml polybrene. The second day
after infection cells from each ﬂask were plated into two 25 cm
ﬂasks in K-SFM and maintained until the cultures became con-
ﬂuent (4–5 days). The medium was then changed to selection
medium consisting of DMEM (containing 2 mM calcium) supple-
mented with 10% FCS and 1 mg/ml hydrocortisone. Cultures
were maintained in differentiation selection medium for 3 weeks
to allow the formation of serum–calcium resistant colonies. PHK
cultures were ﬁxed and stained with 1% methylene blue in
ethanol.
Extension of the life span of primary human keratinocytes after
serum/ calcium trigger
Keratinocytes in 25 cm ﬂasks were infected with 1 ml of the
E6E7 retroviral stock produced in the Phoenix cells. Cell-cultures
established after infection were treated with serum/calcium-selec-
tion medium (DMEM containing 10% serum and1 mg/ml hydro-
cortisone) for 1 week. Treated cells were subsequently passaged at
a ratio of 1:3 in medium containing 3 parts of K-SFM and 1 part of
DMEM with 10% FCS (Sherman and Schlegel, 1996). Culture split
continued in the same manner each time they reached 60–70%
conﬂuence. The experiment was terminated when ﬁbroblast over-
growth was detected.
Extension of the life span of primary human keratinocytes maintained
in serum free medium
Keratinocytes in 25 cm ﬂasks were infected with 1 ml of the
E6E7 retroviral stock produced in Phoenix cells. After retroviral
infection, cultures were divided 1:2 and grown in selection
medium containing 200 mg/ml G-418 for 3 days. Selected cultures
were subsequently grown in KSFM without the drug and split each
time they reached 60–70% conﬂuence (3–14 days). Cultures that
stopped proliferation were maintained in KSFM for 6–8 weeks
with medium change twice a week, regardless of the presence of
ﬁbroblasts, and scored for the appearance of re-emerging kerati-
nocyte colonies.
Clonogenicity assays
After selection in G418 medium, primary keratinocytes trans-
duced with vector or the E6E7 genes were seeded sparsely, in
duplicates, into 6 cm dishes at concentrations of 103, 5103 and
104 per dish. Cells were allowed to grow and proliferate for 14 days
with fresh medium (KSFM) replaced twice a week. Colonies were
stained using 1% methylene blue and counted.
UVB irradiation
After selection in G418 medium, PHKs transduced with the
different HPV E6 genes were plated into 6 cm dishes. Keratinocytes
were irradiated with 300 J/m2 UVB radiation (FLX-35M, Vilber
Lourmat). After irradiation cells were incubated in fresh medium
(KSFM) and harvested at different time points for Western blot
analyses or plated into 96 well plates for XTT assays.
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Viability assays (XTT)
After UVB exposure, PHKs transduced with vector and the
different E6 genes were suspended with trypsin and seeded into
96 wells plates at 3104 cells per well. At 24–48 h post-irradia-
tion, cell viability was determined using the non-radioactive cell
proliferation assay kit (Biological Industries, Israel, Beit Haemek,
Ltd) as previously described (Milrot et al., 2012).
Immunoblot analyses of protein abundance
Immunoblot analyses were carried out as previously described
(Asadurian et al., 2007; Zehbe et al., 2009; Milrot et al., 2012). The
HA tagged E6 proteins were detected with the rat anti HA antibody
(rat, 11867423001; Roche). P53 and survivin were detected with
the mouse monoclonal antibodies, sc-126 and sc-17779, respec-
tively, (Santa-Cruz). Phosphorylation of p53 at serine 15 was
detected with the Phospho-p53 (Ser15) Antibody (9284; Cell
Signaling). Bak and bax were detected with the rabbit polyclonal
antibodies, sc-832 and sc-493, respectively (Santa-Cruz). Caspase
-3 was detected with the rabbit polyclonal antibody 9662
(Cell signaling Technology). Actin mouse monoclonal antibody,
A5441, was from Sigma-Aldrich. Proteins were visualized
by enhanced chemiluminescence (ECL) (Amersham) using
peroxidase-conjugated anti-mouse IgG (115-005-003), anti-rabbit
IgG (111-035-003), or anti rat IgG (112-035-003) (Jackson Immuno
Research Laboratories) according to the manufacturer's instruc-
tions. Protein levels were determined by densitometric scanning
using the TINA software as described (Milrot et al., 2012).
Immunoﬂuorescence staining
Primary keratinocytes transduced with vector, or the different
HPV E6 genes were grown on glass coverslips in 24 well plates.
Cells were exposed to 300 J/m² UVB irradiation and incubated
afterwards with fresh medium for 5 and 24 h. None irradiated
controls (0 h) and post-irradiation cells were washed with
phosphate-buffered saline (PBS) and ﬁxed with 4% paraformalde-
hyde for 20 min. After washing with PBS cells were permeabilized
with 0.1% Triton X-100 for 10 min and incubated in 1% BSA
solution for 1 h. Cells were stained with the rabbit monoclonal
antibody speciﬁc for Ki67 ( SP6, 275R-14) (CELL MARQUE) for 2 h,
followed by 1 h staining with the secondary antibody, Alexa Fluor-
546 goat -anti-rabbit (A-11010, Invitrogen). Cells were also stained
with DAPI (0.004%) and visualized using the confocal microscopy
system Leica SP5. At least 60 cells were inspected in each slide in
different ﬁelds.
Statistical analysis
Data on activity in the various assays are presented as average
(mean) values7SD. Data were subjected to a one-way ANOVA.
Signiﬁcance was accepted at Pr0.05.
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